BI 135585
Sponsors
Boehringer Ingelheim
Conditions
Diabetes Mellitus, Type 2Healthy
Phase 1
Trial to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of BI135585 XX Administered as Tablet and as Solution in Healthy Volunteers
CompletedNCT01146886
Start: 2010-06-30Updated: 2013-11-01
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 135585 XX in Patients With Type 2 Diabetes
CompletedNCT01282970
Start: 2011-02-28Updated: 2014-11-19
Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food
CompletedNCT01286571
Start: 2011-01-31Updated: 2013-11-01